---
title: Ysios Capital - Startup Match Score & Focus Areas
description: Is Ysios Capital the right VC for you? See how their thesis aligns with your startup and discover more active investors focusing on biotechnology and medical devices.
---

[![Höpöhöpö_logo_black](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6_logo_black.png)](https://www.hopohopo.io/?hsLang=io)

- [For Startups](https://www.hopohopo.io?hsLang=io)
- For Investors & Accelerators
  
    - [Screen your deal flow with AI](https://www.hopohopo.io/for-investors?hsLang=io)
    - [Source deals from co-investors and accelerators](https://www.hopohopo.io/source-deal-flow?hsLang=io)
    - [Help your portfolio fundraise](https://www.hopohopo.io/portfolio-fundraising?hsLang=io)
- [For BANs](https://www.hopohopo.io/business-angel-networks?hsLang=io)
- [Pricing](https://www.hopohopo.io/pricing?hsLang=io)
- Resources
  
    - [Maritime Venture program](https://maritime-venture.com/)
    - [Startup Fundraising Essentials](https://www.hopohopo.io/fundraising-essentials?hsLang=io)
    - Investor lists 
          - [EdTech investors in Europe](https://www.hopohopo.io/edtech-investors?hsLang=io)
          - [FinTech investors in Europe](https://www.hopohopo.io/fintech-investors?hsLang=io)
          - [HealthTech investors in Europe](https://www.hopohopo.io/healthtech-investors?hsLang=io)
          - [Climate & Sustainability investors](https://www.hopohopo.io/climate-and-sustainability-investors?hsLang=io)
          - [Gaming investors](https://www.hopohopo.io/gaming-investors?hsLang=io)
          - [SpaceTech investors](https://www.hopohopo.io/spacetech-investors?hsLang=io)
          - [SportsTech investors](https://www.hopohopo.io/sporttech-investors?hsLang=io)
          - [Enterprise Software investors](https://www.hopohopo.io/enterprise-software-investors?hsLang=io)
          - [DefSec investors](https://www.hopohopo.io/defsec-investors?hsLang=io)
          - [Marine Tech investors](https://www.hopohopo.io/marinetech-investors?hsLang=io)
          - [Mobility investors](https://www.hopohopo.io/mobility-investors?hsLang=io)
          - [PropTech investors](https://www.hopohopo.io/proptech-investors?hsLang=io)
          - [Energy investors](https://www.hopohopo.io/energy-investors?hsLang=io)
          - [Top 10 Active investors in Berlin](https://www.hopohopo.io/top-investors-berlin?hsLang=io)

[Log in](https://start.hopohopo.io/) [Sign up](https://start.hopohopo.io/?signup=true)

# Ysios Capital Overview

 Founded in 2008, Ysios Capital is a Spanish venture capital firm specializing in early and development-stage life sciences companies. With over €400 million in assets under management across three dedicated biotech funds, the firm focuses on biotechnology, pharmaceuticals, and medical devices, aiming to address unmet medical needs through innovative therapies and technologies. The team comprises experts with scientific, financial, and legal backgrounds, providing strategic support to portfolio companies in Europe and the United States.

 Is Ysios Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Ysios Capital, along with a list of other relevant VCs, is available on Hopohopo.io.

## Ysios Capital

 VC Fund

![Ysios Capital logo](https://www.hopohopo.io/hubfs/ecosystem-logos-from-platform/5109-0278ee2f5c1082a2848452334ae3c637.png)

## Investment focus

### Invest in

- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
- Caribbean

[View all](https://start.hopohopo.io/?signup=true)

### Product type

- Drugs / Pharma

### Industries / verticals

- BioTech & Life Sciences
- PharmaTech

Investment role

 Lead and follow

Stages

 Series A, Series B or later

First ticket size

 €3,000,000 - €20,000,000

## Contact information

Chief Financial Officer

Inigo Anitua

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Founder & CEO

Joan Bestard

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Head of Legal

Wen Cheng

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Partner

Guillem Laporta

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

Partner

Raul Martin-Ruiz

![LinkedIn](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/carbon_logo-linkedin-grey.svg) ![Email](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6%20-%20Website%20visuals/Icons/Sign-At--Streamline-Core.svg)

## How to approach funds like Ysios Capital

 When approaching Ysios Capital, founders should highlight breakthrough science, strong IP positions, and a clear path to clinical validation. Demonstrate a robust understanding of regulatory and reimbursement landscapes, as well as a credible plan for value inflection points. Emphasize the strength and experience of your scientific and management teams, and be prepared to discuss how your solution addresses significant unmet medical needs with global market potential.

## Find the best-fitting investors for your startup

 Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing. 

[Find your investor matches](https://start.hopohopo.io/?signup=true)

![Investor funnel board](https://www.hopohopo.io/hubfs/Investor%20list%20web%20page%201.png)

[Check the next investor profile](https://www.hopohopo.io/investors/nucleus-capital?hsLang=io)

×

![Hopohopo logo](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/HO-Logo_favicon.png)

## Check your match score in Hopohopo.io

 Check how well Ysios Capital fits your startup and get a list of the best-fitting investors for your fundraising. 

[Sign up](https://start.hopohopo.io/?signup=true)

×

![Hopohopo logo](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/HO-Logo_favicon.png)

## Check Ysios Capital contact details in Hopohopo.io

 Browse all of the contacts related to Ysios Capital and send emails directly from your funnel. 

[Sign up](https://start.hopohopo.io/?signup=true)

- [For Startups](https://www.hopohopo.io/startups?hsLang=io)
- [For Investors and Accelerators](https://www.hopohopo.io/business-angels-and-vcs?hsLang=io)
- [For Business Angel Networks](https://www.hopohopo.io/business-angel-networks?hsLang=io)

- [Blog](https://hopohopo.gitbook.io/fundraising-with-hopohopo/)

### Follow us

<https://www.linkedin.com/company/hopohopo-io>

![Höpöhöpö_logo_white](https://27245214.fs1.hubspotusercontent-eu1.net/hubfs/27245214/H%C3%B6p%C3%B6h%C3%B6p%C3%B6_logo_white.png)

© 2026 Hopohopo.io All rights reserved

[Privacy Policy](https://www.hopohopo.io/privacy-policy?hsLang=io)  
[Terms of Service](https://www.hopohopo.io/terms-of-service?hsLang=io) 

![](https://px.ads.linkedin.com/collect/?pid=4090745&fmt=gif)

```json
{
  "@context" : "https://schema.org",
  "@type" : "Organization",
  "description" : "Founded in 2008, Ysios Capital is a Spanish venture capital firm specializing in early and development-stage life sciences companies. With over €400 million in assets under management across three dedicated biotech funds, the firm focuses on biotechnology, pharmaceuticals, and medical devices, aiming to address unmet medical needs through innovative therapies and technologies. The team comprises experts with scientific, financial, and legal backgrounds, providing strategic support to portfolio companies in Europe and the United States.",
  "logo" : "https://148519842.fs1.hubspotusercontent-eu1.net/hubfs/148519842/ecosystem-logos-from-platform/5109-0278ee2f5c1082a2848452334ae3c637.png",
  "name" : "Ysios Capital",
  "sameAs" : [ "", "" ],
  "url" : "https://www.ysioscapital.com"
}
```